Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001462601 | SCV001666521 | likely benign | not provided | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004038613 | SCV004051057 | uncertain significance | not specified | 2023-08-22 | criteria provided, single submitter | clinical testing | The c.5161C>T (p.R1721C) alteration is located in exon 30 (coding exon 27) of the CEP250 gene. This alteration results from a C to T substitution at nucleotide position 5161, causing the arginine (R) at amino acid position 1721 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |